CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk Healthcare Akums Drugs and Pharmaceuticals Ltd

Akums Drugs and Pharmaceuticals Ltd

BSE 544222 AKUMS INE09XN01023
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

24 filings · 2 material · busiest 2026-08-10

What it files

Filings

24 in the window

  1. 25 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of the Investors/Analysts Meet

    Company Update / Analyst / Investor Meet View filing →

  2. 24 August 2026

    General

    Update On Schedule Of The Investors/Analysts Meet To Be Held On August 25, 2026

    Akums Drugs and Pharmaceuticals Limited has informed the exchange about an update on schedule of the Investors/ Analysts Meet to be held on August 25, 2026

    Company Update / General View filing →

  3. 13 August 2026

    Concall Transcript

    Earnings Call Transcript

    Transcript of Investors/Analysts conference call for the unaudited financial results of Q1 FY 27

    Company Update / Earnings Call Transcript View filing →

  4. 13 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of the Investors/Analysts Meet

    Company Update / Analyst / Investor Meet View filing →

  5. 10 August 2026

    General

    Monitoring Agency Report

    Monitoring Agency Report for the quarter ended June 30, 2026

    Company Update / General View filing →

  6. 10 August 2026

    General

    Newspaper Publication

    Newspaper Publication

    Company Update / General View filing →

  7. 10 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Link of audio recording of Investors/Analysts Conference Call

    Company Update / Analyst / Investor Meet View filing →

  8. 10 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of the Investors/Analysts Meet to be held on August 14, 2026

    Company Update / Analyst / Investor Meet View filing →

  9. 5 August 2026

    Board Meeting

    Board Meeting Intimation for Un-Audited (Standalone & Consolidated) Financial Results For The Quarter Ended On 30Th June, 2026

    Akums Drugs And Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve the un-audited ....

    Board Meeting / Board Meeting View filing →

  10. 5 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27

    Company Update / Analyst / Investor Meet View filing →

  11. 5 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27

    Company Update / Analyst / Investor Meet View filing →

  12. 23 July 2026

    Acquisition

    Acquisition

    Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Acquisition of Oriflame India's Manufacturing Business

    Company Update / Acquisition View filing →

  13. 10 July 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of the 22nd Annual General Meeting of the Company

    AGM/EGM / AGM View filing →

  14. 8 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate pursuant to Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  15. 25 June 2026

    Trading Window

    Closure of Trading Window

    Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  16. 19 June 2026

    General

    Notice And Integrated Annual Report For The Financial Year 2025-26 To Those Members Who Have Not Registered Their E-Mail ID'S

    Notice and Integrated Annual Report for the Financial Year 2025-26 to those members who have not registered their e-mail ID's

    Company Update / General View filing →

  17. 19 June 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisements of the 22nd Annual General Meeting of the Company

    Company Update / Newspaper Publication View filing →

  18. 18 June 2026

    General

    Notice Of The 22Nd Annual General Meeting

    Notice of the 22nd Annual General Meeting

    Company Update / General View filing →

  19. 18 June 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Integrated Annual Report for the FY 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  20. 18 June 2026

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    Business Responsibility and Sustainability Reporting for the FY 2025-26

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  21. 16 June 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement- Information regarding 22nd AGM and Final & Special Dividend

    Company Update / Newspaper Publication View filing →

  22. 10 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of the investor/analysts meets

    Company Update / Analyst / Investor Meet View filing →

  23. 9 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of the Investor/Analyst Meet

    Company Update / Analyst / Investor Meet View filing →

  24. 3 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of the Investor/Analysts Meet

    Company Update / Analyst / Investor Meet View filing →